摘要
目的探讨阿司匹林联合雷贝拉唑治疗急性脑梗死的预后情况。方法对31例急性脑梗死患者随机分为治疗组和对照组,治疗组进行雷贝拉唑和阿司匹林两种药物治疗,对照组仅使用阿司匹林治疗。观察对比这两组患者治疗前后的神经功能缺损评分(NIHSS)、上肢运动功能评分(Fugl-Meyer)、日常生活能力评分(SF)的情况并进行分析。结果治疗组的Fugl-Meyer评分和SF评分高于对照组,两组相比较差异均有统计学显著意义(P<0.05)。结论雷贝拉唑有利于改善神经功能,对于急性脑梗死治疗的效果较好。
Objective To research the effects of aspirin plus leibeirazole （LBLZ） in the treatment of acute cerebral infarction （ACI）. Methods Thirty-one ACI patients were divided into two groups. Treatment group received aspirin and LBLZ, contral group only received aspirin treatment. NIHSS, Fugl-Meyer and SF before and after treatment in groups of patients were observed and analyzed. Results The treatment group is lower than the control group in NIHSS and is higher in Fugl-Meyer and SF. The two groups had significant difference （ P 〈 0.05 ）. Conclusion LBLZ can improve neurologic function, and play a posttive role in the treatment of ACI.
出处
《中国临床新医学》
2009年第12期1281-1283,共3页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词
阿司匹林
雷贝拉唑
急性脑梗死
预后
Aspirin
Leibeirazole （LBLZ）
Acute cerebral infarction （ACI）
Prognosis
作者简介
作者简介：杨勇（1964-），男，大学本科，学士学位，副主任医师，研究方向：脑血管病。E-mail：yy2yxj@163．com
